Drug Approval | October 14, 2024
Indoco Remedies receives OAI status from USFDA for Goa plant 2 & 3
Indoco is comprehensively working on the remedial action plan
Indoco is comprehensively working on the remedial action plan
The GMP certificate will allow the manufacturing site in Hervás, Cáceres to manufacture active ingredients for the pharmaceutical industry that is based on medicinal plants
This product is categorized as antacids, antiflatulents and anti-Ulcerants
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
Aims to achieve CDMO sales of US$ 400 million by 2028
We now rank 3rd in pharmaceutical production by volume and 14th by value
Clarity in regulatory frameworks and pathways help in preventing delays in accessing quality-assured, affordable medicines
DKSH has entered into an exclusive partnership with R-Biomeds to bring the necessary medication to patients in Cambodia
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
Subscribe To Our Newsletter & Stay Updated
